Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.

NCT00290901 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

754

Enrollment

INDUSTRY

Sponsor class

Conditions

Back Pain

Interventions

DRUG: Tramadol Hydrochloride 50mg
DRUG: Celebrex 200mg

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.